Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Franchi

Showing results (21-30 of 146) with videos related to

Pageof 15
Sort By:
JACC. Cardiovascular Interventions|January 21, 2017
Drug-Drug Interactions When Switching Between Intravenous and Oral P2Y<sub>12</sub> Receptor Inhibitors: How Real Is It?Fabiana Rollini, Francesco Franchi, Dominick J Angiolillo
Interventional Cardiology Clinics|November 26, 2016
Switching P2Y<sub>12</sub> Receptor Inhibiting TherapiesFabiana Rollini, Francesco Franchi, Dominick J Angiolillo
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 21, 2017
Crushed ticagrelor in comatose patients treated with primary percutaneous coronary interventionFabiana Rollini, Francesco Franchi, Dominick J Angiolillo
Journal of the American College of Cardiology|January 14, 2017
Reply: Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH StudyFabiana Rollini, Francesco Franchi, Dominick J Angiolillo
JACC. Cardiovascular Interventions|January 21, 2022
Reply: The Effects of Cangrelor on Platelet Aggregation in STEMI Patients: Methodological or Pharmacological Issues?Francesco Franchi, Fabiana Rollini, Dominick J Angiolillo
Nature Reviews. Cardiology|August 19, 2015
Switching P2Y12-receptor inhibitors in patients with coronary artery diseaseFabiana Rollini, Francesco Franchi, Dominick J Angiolillo
Journal of the American College of Cardiology|March 17, 2018
The Quest for the Optimal Periprocedural Antithrombotic Treatment Strategy in ACS Patients Undergoing PCIDominick J Angiolillo, Fabiana Rollini, Francesco Franchi
Nature Reviews. Cardiology|February 24, 2017
Antithrombotic therapy for patients with STEMI undergoing primary PCIFrancesco Franchi, Fabiana Rollini, Dominick J Angiolillo
Thrombosis and Haemostasis|March 19, 2024
The Lipid-Platelet Interplay: Unraveling the Effects of PCSK9 Inhibition on Platelet ReactivityLuis Ortega-Paz, Francesco Franchi, Dominick J Angiolillo
Expert Opinion on Drug Metabolism & Toxicology|August 25, 2020
Clopidogrel drug interactions: a review of the evidence and clinical implicationsChang Hoon Lee, Francesco Franchi, Dominick J Angiolillo
Pageof 15

Showing results (21-30 of 146) with videos related to

Sort By:
Pageof 15
JACC. Cardiovascular Interventions|January 21, 2017
Drug-Drug Interactions When Switching Between Intravenous and Oral P2Y<sub>12</sub> Receptor Inhibitors: How Real Is It?Fabiana Rollini, Francesco Franchi, Dominick J Angiolillo
Interventional Cardiology Clinics|November 26, 2016
Switching P2Y<sub>12</sub> Receptor Inhibiting TherapiesFabiana Rollini, Francesco Franchi, Dominick J Angiolillo
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 21, 2017
Crushed ticagrelor in comatose patients treated with primary percutaneous coronary interventionFabiana Rollini, Francesco Franchi, Dominick J Angiolillo
Journal of the American College of Cardiology|January 14, 2017
Reply: Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH StudyFabiana Rollini, Francesco Franchi, Dominick J Angiolillo
JACC. Cardiovascular Interventions|January 21, 2022
Reply: The Effects of Cangrelor on Platelet Aggregation in STEMI Patients: Methodological or Pharmacological Issues?Francesco Franchi, Fabiana Rollini, Dominick J Angiolillo
Nature Reviews. Cardiology|August 19, 2015
Switching P2Y12-receptor inhibitors in patients with coronary artery diseaseFabiana Rollini, Francesco Franchi, Dominick J Angiolillo
Journal of the American College of Cardiology|March 17, 2018
The Quest for the Optimal Periprocedural Antithrombotic Treatment Strategy in ACS Patients Undergoing PCIDominick J Angiolillo, Fabiana Rollini, Francesco Franchi
Nature Reviews. Cardiology|February 24, 2017
Antithrombotic therapy for patients with STEMI undergoing primary PCIFrancesco Franchi, Fabiana Rollini, Dominick J Angiolillo
Thrombosis and Haemostasis|March 19, 2024
The Lipid-Platelet Interplay: Unraveling the Effects of PCSK9 Inhibition on Platelet ReactivityLuis Ortega-Paz, Francesco Franchi, Dominick J Angiolillo
Expert Opinion on Drug Metabolism & Toxicology|August 25, 2020
Clopidogrel drug interactions: a review of the evidence and clinical implicationsChang Hoon Lee, Francesco Franchi, Dominick J Angiolillo
Pageof 15